Table 1.
Clinical characteristics of cohort at study entry, mean serum albumin <3.5/3.2 versus ≥3.5/3.2 to 4.0/3/7 versus ≥4.0/3.7 g/dl (BCG/BCP), n = 675a
| Baseline Clinical Characteristic | Mean Serum Albumin
|
P | ||
|---|---|---|---|---|
| < 3.5/3.2 g/dl(n = 125) | ≥3.5/3.2 and <4.0/3/7 g/dl(n = 263) | ≥4.0/3.7 g/dl(n = 287) | ||
| Age (yr; mean [SD]) | 16 (1.7) | 15.8 (1.7) | 16.1 (1.6) | 0.217b |
| White race (n [%]) | 60 (48.0) | 116 (44.0) | 153 (53.0) | 0.096c |
| Male gender (n [%]) | 55 (44.0) | 132 (50.2) | 166 (58.0) | 0.021c,d |
| Hispanic ethnicity (n [%]) | 17 (13.6) | 58 (22) | 79 (27.5) | 0.030c,d |
| Nephrotic syndrome/FSGS (n [%]) | 29 (23.2) | 48 (18.3) | 43 (15.0) | 0.129c |
| HD access type: catheter (n [%]) | 74 (59.2) | 131 (49.8) | 111 (38.9) | 0.001c,d |
| Hemoglobin (g/dl; mean [SD]) | 10.1 (1.8) | 11 (1.6) | 11.5 (1.4) | 0.000b,d |
| Serum ferritin (ng/ml; mean [SD]) | 387 (469) | 274 (259) | 279 (285) | 0.005b,d |
| BMI (kg/m2; mean [SD]) | 20.2 (7.4) | 21.3 (7.6) | 21.1 (7.8) | 0.401b |
| spKt/V (mean [SD]) | 1.4 (0.4) | 1.5 (0.4) | 1.5 (0.4) | 0.096b |
| Dialysis vintage (d; mean [SD]) | 257 (590) | 540 (917) | 542 (759) | 0.002b,d |
| ESRD duration (d; mean [SD]) | 843 (1407) | 1072 (SD 1396) | 1054 (1401) | 0.283b |
| Transplant during study (n [%]) | 57 (45.6) | 121 (46.0) | 148 (51.6) | 0.342c |
| Peritoneal dialysis exposure (n [%]) | 10 (8.0) | 18 (6.8) | 12 (4.2) | 0.231c |
a
Bromcresol green/bromcresol purple (BCG/BCP) laboratory methods. BMI, body mass index; HD, hemodialysis; spKt/V, single-pool Kt/V.
b
ANOVA.
c
χ2
d
P < 0.05.